Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock

Intensive Care Medicine

Volumn 25, Issue 9, 1999, Pages 942-948

  Levy, B ^a   Nace, L ^a   Bollaert, P E ^a   Dousset, B ^a   Mallie, J P ^b   Larcan, A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Catecholamines; Dobutamine; Dopexamine; Gastric tonometry; Intramucosal pH; Septic shock

Indexed keywords

CARBON DIOXIDE; CREATININE; DOBUTAMINE; DOPEXAMINE; LACTIC ACID; NORADRENALIN; PYRUVIC ACID; SODIUM;

ADULT; AGED; ARTICLE; BLOOD VOLUME; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIURESIS; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INDEX; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; OXYGEN CONSUMPTION; PULMONARY ARTERY OCCLUSION; RANDOMIZED CONTROLLED TRIAL; REGIONAL PERFUSION; RESUSCITATION; SEPTIC SHOCK; SODIUM EXCRETION; UNIVERSITY HOSPITAL;

ANALYSIS OF VARIANCE; CARBON DIOXIDE; DOBUTAMINE; DOPAMINE; FEMALE; GASTRIC MUCOSA; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MALE; MIDDLE AGED; NOREPINEPHRINE; PARTIAL PRESSURE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SYMPATHOMIMETICS; VASODILATOR AGENTS;

EID: 0032823705     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050986     Document Type: Article

References (32)

1. 1. Fiddian-Green RG (1993) Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med 21: S103-S107
2. 2. Russell JA (1997) Gastric tonometry: does it work? Intensive Care Med 23: 3-6
3. 3. Silverman HJ, Tuma P (1992) Effects of dobutamine infusions and packed red blood cell transfusions. Chest 102: 184-188
4. 4. Gutierrez G, Clark C, Brown SD, Ortiz V, Nelson C (1994) Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150: 324-329
5. 5. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically ill. Chest 108: 1648-1654
6. 6. Smithies MN, Yee TH, Jackson L, Beale R, Bihari D (1994) Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 22: 789-795
7. 7. Neviere R, Mathieu D, Chagnon JL, Lehleu N, Wattel F (1996) The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154: 1684-1688
8. 8. Temmesfeld-Wollbrück B, Szalay A, Olchewski H, Grimminger F, Seeger W (1997) Advantage of buffered solutions or automated capnometry in air-filled balloons for use in gastric tonometry. Intensive Care Med 23 :423-427
9. 9. Levy B, Bollaert PE, Lucchelli JP, Sadouno LO, Nace L, Larcan A (1997) Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic patients. Crit Care Med 25: 1649-1654
10. 10. Temmesfeld-Wollbrück B, Szalay A, Mayer K, Olschewski H, Seeger W, Grimminger F (1998) Abnormalities of gastric mucosal oxygenation in septic shock. Partial responsiveness to dopexamine. Am J Respir Crit Care Med 157: 1586-1592
11. 11. Levraut J, Ciebiera JP, Chave S, et al. (1998) Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 157: 1021-1026
12. 12. Reinelt H, Radermacher P, Fischer G, Trunk E, Wiedeck H, Mezödy M, Georgieff M, Vogt J (1997) Dobutamine and dopexamine and the splanchnic metabolic response in septic shock. Clin Intensive Care 8: 38-41
13. 13. Tighe D, Moss R, Heywood G, Al-Saady N, Bennett D (1995) Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. Crit Care Med 23: 1997-2007
14. 14. Geisser W, Träger K, Hähn A, Georgieff M, Ensinger H (1997) Metabolic and calorigenic effects of dopexamine in healthy volunteers. Crit Care Med 25: 1332-1337
15. 15. Uusaro A, Hartikainen J, Parviainen M, Takala J (1995) Metabolic stress modifies the thermogenic effect of dobutamine in man. Crit Care Med 23: 674-680
16. 16. Reinelt P, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, Georgieff M (1999) Impact of exogenous β-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 27: 325-331
17. 17. Duke GJ, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine. Crit Care Med 22: 1919-1925
18. 18. Juste RN, Panikkar K, Soni N (1998) The effects of low-dose dopamine on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 24: 564-568
19. 19. Richer M, Robert S, Lebel M (1996) Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 24: 1150-1156
20. 20. Schwartz LB, Gewertz BIL (1988) The renal response to low dose dopamine. J Surg Res 45: 564-588
21. 21. Martin C, Eon B, Saux P, Aknin P, Gouin F (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282-285
22. 22. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF (1996) Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 22: 213-219
23. 23. Fiddian-Green RG (1995) Gastric intramucosal pH, tissue oxygenation and acid-base balance. Br J Anaesth 74: 591-606
24. 24. Levy B, Bollaert PE, Charpentíer C, Nace L, Audibert G, Bauer Ph, Nabet P, Larcan A (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock. A prospective, randomized study. Intensive Care Med 23: 282-287
25. 25. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K (1999) Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27: (in press)
26. 26. Radermacher P, Buhl R, Santak B, Klein M, Kniemeyer HW, Becker H, Tarnow J (1995) The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med 21: 414-421
27. 27. Eichelbrönner O, Reinelt H, Wiedeck H, Mezödy M, Rossaint R, Georgieff M, Radermacher P (1996) Aerosolized prostacyclin and inhaled nitric oxide in septic shock - different effects on splanchnic oxygenation. Intensive Care Med 22: 880-887
28. 2 in intestine during low flow. J Appl Physiol 76: 2443-2451
29. 29. Elizade I, Hernandez C, Llaeh J. Monton C, Bordas JM, Pique JM, Torres A (1998) Gastric intramucosal acidosis in mechanically ventilated patients: role of mucosal blood flow. Crit Care Med 26: 827-832
30. 30. Brinkmann A, Caizia E, Träger K, Radermacher P (1998) Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance. Intensive Care Med 24: 542-555
31. 2. Crit Care Med 26: 1479-1481
32. 32. Silva E, DeBacker D, Creteur J, Vincent JL (1998) Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 26: 1749-1758